These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6125677)

  • 1. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
    Woods JC; Spriggs AI; Harris H; McGee JO
    Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
    Singer S; Boddington MM; Hudson EA
    J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.
    Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY
    J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of the immunocytochemical study of body fluids.
    Li CY; Ziesmer SC; Wong YC; Yam LT
    Acta Cytol; 1989; 33(5):667-73. PubMed ID: 2675517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic interest of the monoclonal antibody CA1 in malignant pleural effusion.
    Font P; Palacìn A; Font J; Faus R; Molina R; Ballesta AM; Cardesa A; Ingelmo M
    Int J Biol Markers; 1987; 2(3):157-60. PubMed ID: 2453591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
    Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF
    Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.
    Bramwell ME; Ghosh AK; Smith WD; Wiseman G; Spriggs AI; Harris H
    Cancer; 1985 Jul; 56(1):105-10. PubMed ID: 2408723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in the cytodiagnosis of serous effusions.
    al-Nafussi A; Carder PJ
    Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric identification of cancer cells in effusions with Ca1 monoclonal antibody.
    Czerniak B; Papenhausen PR; Herz F; Koss LG
    Cancer; 1985 Jun; 55(12):2783-8. PubMed ID: 3888371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
    Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
    Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies.
    Shaw P; Buckman R; Law J; Baumal R; Marks A
    Tumour Biol; 1988; 9(2-3):101-9. PubMed ID: 3041546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.
    To A; Coleman DV; Dearnaley DP; Ormerod MG; Steele K; Neville AM
    J Clin Pathol; 1981 Dec; 34(12):1326-32. PubMed ID: 7035498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical staining of serous effusions: an additional method in the routine cytology practice?
    Lidang Jensen M; Johansen P
    Cytopathology; 1994 Apr; 5(2):93-103. PubMed ID: 8038428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour associated antigens in diagnosis of serous effusions.
    Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
    J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy.
    Kahn HJ; Hanna W; Yeger H; Baumal R
    Am J Pathol; 1982 Nov; 109(2):206-14. PubMed ID: 6182803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of carcinoembryonic antigen for identification of human tumor cells in malignant effusions.
    Horowitz AT; Fuks Z; Okon E; Biran S; Treves AJ
    Oncology; 1983; 40(1):18-25. PubMed ID: 6337362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a pool of monoclonal antibodies in diagnosing cells from serous cavities.
    Cappellari A; Bagarella M; Ménard S; Calabrese M; Colnaghi MI
    Tumori; 1993 Jun; 79(3):211-3. PubMed ID: 8236507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of immunocytochemistry in the study of malignant effusions.
    Mason MR; Bedrossian CW; Fahey CA
    Diagn Cytopathol; 1987 Sep; 3(3):215-21. PubMed ID: 3311665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology.
    Singh G; Dekker A; Ladoulis CT
    Acta Cytol; 1978; 22(6):487-9. PubMed ID: 282748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.